Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants

Journal of Developmental Origins of Health and Disease

Volumn 3, Issue 4, 2012, Pages 262-270

  Gordon, A L ^a,b   Lopatko, O V ^b   Haslam, R R ^c   Stacey, H ^c   Pearson, V ^d   Woods, A ^d   Fisk, A ^d   White, J M ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d Drug & Alcohol Services South Australia   (Australia)

Author keywords

Buprenorphine; Methadone; Morphine treatment; Neonatal abstinence syndrome; Non opioid exposed controls

Indexed keywords

EID: 84888371939     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174412000190     Document Type: Article

References (43)

1. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998; 25, 139-151. (Pubitemid 28141705)
2. Finnegan LP, Kandall SR. Maternal and neonatal effects of alcohol and drugs. In Substance Abuse (eds. Lowinson JH, Ruiz P, Millman RB, Langrod JG), 3rd edn, 1997; pp. 513-534. Williams and Wilkins: Baltimore.
3. Colombini N, Elias R, Busuttil M, et al. Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone. Pharm World Sci. 2008; 30, 227-234.
4. Ebner N, Rohrmeister K, Winklbaur B, et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend. 2007; 87, 131-138. (Pubitemid 46215932)
5. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, doubledummy comparison study. Addiction. 2006; 101, 275-281. (Pubitemid 43351601)
6. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363, 2320-2331.
7. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiatedependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend. 2006; 82, 250-257.
8. Jackson L, Ting A, McKay S, Galea P, Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004; 89, F300-F304. (Pubitemid 38869667)
9. Kraft WK, Gibson E, Dysart K, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008; 122, e601-e607.
10. Langenfeld S, Birkenfeld L, Herkenrath P, et al. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend. 2005; 77, 31-36. (Pubitemid 39656097)
11. Johnson K, Gerada C, Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2003; 88, F2-F5. (Pubitemid 36084199)
12. Kuschel C. Managing drug withdrawal in the newborn infant. Semin Fetal Neonatal Med. 2007; 12, 127-133. (Pubitemid 46366884)
13. Osborn DA, Jeffery HE, Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2005, CD002059.
14. Winklbaur B, Jung E, Fischer G. Opioid dependence and pregnancy. Curr Opin Psychiatry. 2008; 21, 255-259. (Pubitemid 351489345)
15. Winklbaur B, Kopf N, Ebner N, et al. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008; 103, 1429-1440.
16. Crane E, Morris JK. Changes in maternal age in England and Wales - implications for Down syndrome. DSRP. 2006; 10, 41-43.
17. Godding V, Bonnier C, Fiasse L, et al. Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Pediatr Res. 2004; 55, 645-651. (Pubitemid 38405852)
18. Llewellyn-Jones D. Fundamentals of Obstetrics and Gynecology, 7th edn, 1999. Mosby: Barcelona.
19. Merrick J, Merrick E, Morad M, Kandel I. Fetal alcohol syndrome and its long-term effects. Minerva Pediatr. 2006; 58, 211-218. (Pubitemid 44265113)
20. Kraft WK, Dysart K, Greenspan JS, et al. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. 2011; 106, 574-580.
21. Fischer G, Johnson RE, Eder H, et al. Treatment of opioiddependent pregnant women with buprenorphine. Addiction. 2000; 95, 239-244. (Pubitemid 30111244)
22. Blinick G, Jerez E, Wallach RC. Methadone maintenance, pregnancy, and progeny. JAMA. 1973; 225, 477-479.
23. Kaltenbach K, Finnegan LP. Perinatal and developmental outcome of infants exposed to methadone in-utero. Neurotoxicol Teratol. 1987; 9, 311-313.
24. Kandall SR, Albin S, Lowinson J, et al. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics. 1976; 58, 681-685.
25. Wouldes TA, Roberts AB, Pryor JE, Bagnall C, Gunn TR. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol Teratol. 2004; 26, 23-34. (Pubitemid 38299106)
26. Wen SW, Kramer MS, Usher RH. Comparison of birth weight distributions between Chinese and Caucasian infants. Am J Epidemiol. 1995; 141, 1177-1187.
27. Singh GK, Yu SM. Birthweight differentials among Asian Americans. Am J Public Health. 1994; 84, 1444-1449. (Pubitemid 24290943)
28. Humphrey MD, Holzheimer DJ. Differing influences on Aboriginal and non-Aboriginal neonatal phenotypes: a prospective study. Med J Aust. 2001; 174, 503-506. (Pubitemid 32479338)
29. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr. 1991; 118, 933-937.
30. Ballard JL. Treatment of neonatal abstinence syndrome with breast milk containing methadone. J Perinatol Neonat Nurs. 2002; 15, 76-85. (Pubitemid 33603441)
31. Begg EJ, Malpas TJ, Hackett LP, Ilett KF. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Br J Clin Pharmacol. 2001; 52, 681-685. (Pubitemid 34015626)
32. Johnson RE, Jones HE, Jasinski DR, et al. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001; 63, 97-103. (Pubitemid 32293533)
33. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachatre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997; 62, 569-571. (Pubitemid 28214935)
34. McCarthy JJ, Posey BL. Methadone levels in human milk. J Hum Lact. 2000; 16, 115-120.
35. Schindler SD, Eder H, Ortner R, et al. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003; 98, 103-110. (Pubitemid 36044342)
36. McGlone L, Mactier H, Hamilton R, et al. Visual evoked potentials in infants exposed to methadone in utero. Arch Dis Child. 2008; 93, 784-786.
37. van Baar AL, de Graaff BM. Cognitive development at preschool-age of infants of drug-dependent mothers. Dev Med Child Neurol. 1994; 36, 1063-1075.
38. van Baar AL, Soepatmi S, Gunning WB, Akkerhuis GW. Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr Suppl. 1994; 404, 40-46. (Pubitemid 24349136)
39. Whitham JN, Spurrier NJ, Sawyer MG, et al. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol. 2010; 32, 280-288.
40. Voepel-Lewis T, Marinkovic A, Kostrzewa A, Tait AR, Malviya S. The prevalence of and risk factors for adverse events in children receiving patient-controlled analgesia by proxy or patient-controlled analgesia after surgery. Anesth Analg. 2008; 107, 70-75.
41. Jasinski DR, Pevnick JS, Griffith JD. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry. 1978; 35, 501-516. (Pubitemid 8337042)
42. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994; 55, 569-580. (Pubitemid 24192243)
43. Ward J, Mattick RP, Hall W (eds) Methadone Maintenance Treatment and Other Opioid Replacement Therapies, 1998. Hardwood Academic Publishers: Amsterdam.